Correction to: Nature Reviews Drug Discovery https://doi.org/10.1038/s41573-021-00252-y, published online 5 August 2021.
Errors in the description of side effects reported for the kinase inhibitor deucravacitinib have been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Attwood, M.M., Fabbro, D., Sokolov, A.V. et al. Author Correction: Trends in kinase drug discovery: targets, indications and inhibitor design. Nat Rev Drug Discov 20, 798 (2021). https://doi.org/10.1038/s41573-021-00303-4
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41573-021-00303-4
This article is cited by
-
Large-scale comparison of machine learning methods for profiling prediction of kinase inhibitors
Journal of Cheminformatics (2024)
